| ABSTRACT Objective: To evaluate the level of diagnosis and treatment and the clinical application of monopathy quality control in patients with acute myocardial infarction in our hospital. Methods:A total of 79 patients with acute myocardial infarction, who were randomly sampled and had once been diagnosed during November 2009 to January 2011, were analyzed retrospectively about the state of monopathy quality control. Results:A total of 61 AMI patients had received the evaluation of LVEF (left ventricular function tests) and 68 AMI patients had received the assessments of LDL cholesterol. The average time of door to needle in the patients who received thrombolytic therapy was 1.5h, and the average time of door to balloon in the patients with STEMI who received p PCI therapy was 2.23±2.22 h. The patients who treated with Aspirin immediately after arriving hospital account for97.5%. The rates of using Aspirin, β-blocker, ACEI/ARB and Stains during the hospitalization were respectively 100%，79.7%，87.3% and97.5%.The use rates of Aspirin, β-blocker, ACEI/ARB and Stains, which were prescribed at discharged were 92.1%,72.4%, 73.7% and 93.4%. There were 59 AMI patients had received the health education at discharge. The average days of hospital stay in AMI patients were 10.54 days while the average cost of treatments was 50 023.18RMB.Conclusion:The diagnosis and treatments basically met the demands of monopathy quality control in patients with acute myocardial infarction in our hospital, while the early reperfusion therapy needs to be improved. |
